SMYD1 and gastric cancer: Additionally, in gastric cancer, high expression of ankyrin repeat and SOCS box-containing 5 (ASB5), secreted frizzled-related protein 1 (SFRP1), SMYD1, and tachykinin receptor 2 (TACR2) is associated with short survival times and high risk in these patients14.